Keryx says anemia drug succeeds in study of kidney patients
(Reuters) - Keryx Biopharmaceuticals Inc on Tuesday said its drug to treat iron deficiency anemia in chronic kidney disease patients not yet requiring dialysis met the goals of a late stage clinical trial, potentially paving the way for an expanded approval of the treatment.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Anemia | Chronic Kidney Disease | Clinical Trials | Dialysis | Health | Study | Urology & Nephrology